Valuation: Nipro Corporation

Market Cap 255B 1.56B 1.37B 1.27B 1.17B 2.2B 151B 2.24B 15.23B 5.94B 73.61B 5.85B 5.72B P/E 2027 *
17.5x
P/E 2028 * 12.9x
Enterprise Value 766B 4.68B 4.11B 3.82B 3.51B 6.59B 453B 6.71B 45.68B 17.82B 221B 17.55B 17.17B EV / Sales 2027 *
1.09x
EV / Sales 2028 * 1.02x
Free-Float
87.38%
Yield 2027 *
2.2%
Yield 2028 * 2.94%
07-14 Jefferies Adjusts Nipro's Price Target to 1,700 Yen From 1,500 Yen, Keeps at Hold MT
05-12 Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and Fiscal Year Ending March 31, 2027 CI
05-12 Nipro Corporation Announces Year-End Dividend for Fiscal Year Ended March 31, 2026, Payable on June 10, 2026; Provides Second Quarter-End and Year-End Dividend Guidance for Fiscal Year Ending March 31, 2027 CI
05-01 Jefferies Adjusts Nipro's Price Target to 1,500 Yen From 1,300 Yen, Keeps at Hold MT
03-11 Nipro Fixes Record Date for Fiscal 2026 Year-End Dividend MT
02-08 Nipro Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
12-24 Nipro Corporation Announces Establishment of Wholly Owned Subsidiary in Singapore CI
11-10 Nipro Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending March 31, 2026, Payable on December 10, 2025 CI
25-06-10 Samsung Bioepis Partners With Nipro to Commercialize Biosimilars in Japan MT
25-06-09 Samsung Bioepis Co., Ltd. Enters into A Strategic Partnership with NIPRO Corporation for Commercialization of Multiple Biosimilars in Japan CI
25-05-13 Jefferies Adjusts Nipro's Price Target to 1,300 Yen from 1,400 Yen, Keeps at Hold MT
25-05-12 Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2025 and Fiscal Year Ending March 31, 2026 CI
25-05-12 Nipro Corporation Announces Dividend for the Year Ended March 31, 2025, Effective June 27, 2025; Provides Dividend Guidance for the Second Quarter End of Fiscal Year Ending March 31, 2026 CI
1 day+1.06%
1 week-1.38%
Current month-0.41%
1 month-3.53%
3 months+2.41%
6 months+9.10%
Current year+6.30%
1 week 1,544
Extreme 1544
1,613.5
1 month 1,531
Extreme 1531
1,648.5
Current year 1,401
Extreme 1401
1,760.5
1 year 1,367.5
Extreme 1367.5
1,760.5
3 years 1,015.5
Extreme 1015.5
1,760.5
5 years 987
Extreme 987
1,760.5
10 years 908
Extreme 908
1,760.5
Manager TitleAgeSince
President 58 2025-06-25
Chief Administrative Officer 57 2025-06-25
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 81 2025-06-25
Director/Board Member 53 2009-05-31
Director/Board Member 58 2009-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%-1.38%+14.72%+50.89% 1.56B
+0.18%+1.94%-19.93%-11.85% 175B
+0.15%-1.85%-10.87%-7.81% 105B
+1.49%-0.95%+3.96%+58.40% 59.35B
-1.13%-2.60%+26.37%+54.76% 50.71B
-0.12%-4.35%-16.22%-42.24% 42.15B
+1.21%-8.47% - - 31.82B
-1.33%-9.62%-18.45%-46.03% 27.2B
-0.82%-1.92%+56.39%-5.79% 25.11B
+0.03%-4.74%-6.58%-9.24% 20.53B
Average +0.09%-3.25%+3.27%+4.56% 53.89B
Weighted average by Cap. +0.17%-1.51%-5.81%+0.11%

Financials

2027 *2028 *
Net sales 700B 4.27B 3.76B 3.49B 3.21B 6.02B 414B 6.13B 41.74B 16.28B 202B 16.04B 15.69B 729B 4.45B 3.91B 3.63B 3.34B 6.27B 431B 6.38B 43.46B 16.95B 210B 16.7B 16.34B
Net income 14.78B 90.19M 79.33M 73.69M 67.78M 127M 8.73B 129M 881M 344M 4.26B 339M 331M 19.97B 122M 107M 99.56M 91.57M 172M 11.8B 175M 1.19B 464M 5.76B 457M 448M
Net Debt 511B 3.12B 2.74B 2.55B 2.34B 4.39B 302B 4.47B 30.46B 11.88B 147B 11.7B 11.45B 492B 3B 2.64B 2.45B 2.25B 4.23B 290B 4.3B 29.31B 11.43B 142B 11.26B 11.02B
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Date Price Change Volume
26-07-24 JP¥1,570.00 +1.06% 530,000
26-07-23 JP¥1,553.50 -2.33% 731,700
26-07-22 JP¥1,590.50 -0.53% 350,500
26-07-21 JP¥1,599.00 +0.44% 524,300
26-07-17 JP¥1,592.00 +0.76% 572,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,553.50JPY
Average target price
1,982.00JPY
Spread / Average Target
+27.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 8086 Stock